<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7294518\results\search\disease\results.xml">
  <result pre="response in 144 individuals from 3 different subpopulations: HIV patients," exact="tuberculosis" post="patients and healthy individuals first tested in 2016 and"/>
  <result pre="Yellow fever virus, Bussuquara, Cacipacoré, Ilhéus, Rocio and Saint Louis" exact="encephalitis" post="virus might elicit unique flaviviral antibody responses that impact"/>
  <result pre="HIV-positive patients and healthy individuals from the UHPES and treated" exact="tuberculosis" post="patients from the José Silveira Foundation-Brazilian Institute for Investigation"/>
  <result pre="samples were obtained from 28 patients on treatment for active" exact="pulmonary tuberculosis;" post="93 immunologically stable HIV-positive patients under antiretroviral therapy; and"/>
  <result pre="level of seroreversion did not differ significantly among HIV-positive and" exact="tuberculosis" post="patients [25 serorevertants (26.9%) versus 5 serorevertants (17.8%); Fisher,"/>
  <result pre="in 2017–2018 (shown in gray) in the HIV patients (HIV)," exact="tuberculosis" post="patients (TB), healthy individuals (HI) subpopulations and total patients"/>
  <result pre="with generally lower antibody responses of HIV-positive individuals, e.g., following" exact="hepatitis" post="A virus vaccination [19]. However, the decrease of ELISA"/>
 </snippets>
</snippetsTree>
